| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 12/09/2004 | US20040248950 Apo ai expression accelerating agent |
| 12/09/2004 | US20040248941 such as 4-[2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazol-1-yl]-1,3-dioxolan-2-one, used as prodrugs to lansoprazole; proton pump inhibitors; antiulcer agents |
| 12/09/2004 | US20040248938 Substituted piperidines |
| 12/09/2004 | US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents |
| 12/09/2004 | US20040248932 Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence |
| 12/09/2004 | US20040248931 Poly(ADP-ribose)polymerase inhibitors; cerebral infarction; such as 3-[2-(3-hydroxypyrrolidin-1-yl)ethyl]-5-methyl-2H-isoquinolin-1-one; synthesis |
| 12/09/2004 | US20040248898 Group V and/or X secretory phospholipase A2 inhibition; suppressing degeneration of serum lipoproteins |
| 12/09/2004 | US20040248896 Pyridine substituted furan derivatives as raf kinase inhibitors |
| 12/09/2004 | US20040248890 Voltage gated sodium and calcium channel inhibitors |
| 12/09/2004 | US20040248883 Novel heteroaryl derivatives, their preparation and use |
| 12/09/2004 | US20040248853 Antiinflammatory agents; antihistamines; adult respiratory distress syndrome; antidiabetic agents; inflammatory bowel disorders |
| 12/09/2004 | US20040247523 Diagnosing and localizing sites of inflammation and perfusion abnormalities (e.g. reperfusion injury, vulnerable plaque, bacterial endocarditis or cardiac transplant rejection) in a single dual isotope imaging procedure, particularly CT imaging, ultrasound, or scintigraphy. |
| 12/09/2004 | CA2753318A1 Substituted pyrrole derivatives |
| 12/09/2004 | CA2527731A1 Substituted pyrrole derivatives as hmg-coa reductase inhibitors |
| 12/09/2004 | CA2527583A1 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 12/09/2004 | CA2527197A1 4-amino-2(5h)-furanones useful as cholecystokinin antagonists |
| 12/09/2004 | CA2527192A1 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 12/09/2004 | CA2527017A1 Quinazolines and pyrido [3,4-d] pyrimidines as receptor tyrosine kinase inhibitors |
| 12/09/2004 | CA2526749A1 3-[2-(3-amino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
| 12/09/2004 | CA2526730A1 Substituted pyrrole derivatives |
| 12/08/2004 | EP1484614A1 Fluorescent sensor for phosphate ion and phosphorylated peptide |
| 12/08/2004 | EP1484327A1 Nitrogenous heterocyclic compound and medicine thereof |
| 12/08/2004 | EP1483266A1 Spiro compounds with npy antagonistic activity |
| 12/08/2004 | EP1483262A1 Coumarines useful as biomarkers |
| 12/08/2004 | EP1483259A1 Pyrimidines as novel openers of potassium ion channels |
| 12/08/2004 | EP1483256A2 Process for making chiral 1,4-disubstituted piperazines |
| 12/08/2004 | EP1483255A1 Process for synthesizing chiral n-aryl piperazines |
| 12/08/2004 | EP1483246A1 5-substituted-alkylaminopyrazole derivatives as pesticides |
| 12/08/2004 | EP1483245A2 5-substituted-alkylaminopyrazole derivatives as pesticides |
| 12/08/2004 | EP1483243A1 PREPARATION OF N1-(2’-PYRIDYL)-1,2-PROPANEDIAMINE SULFAMIC ACID AND ITS USE IN THE SYNTHESIS OF BIOLOGICALLY ACTIVE PIPERAZINES |
| 12/08/2004 | EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 12/08/2004 | EP1482940A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 12/08/2004 | EP1482939A1 Preparation of paroxetine involving novel intermediates |
| 12/08/2004 | EP1482932A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 12/08/2004 | EP1482931A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 12/08/2004 | EP1482930A1 Peptide deformylase inhibitors |
| 12/08/2004 | EP1482928A2 Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 12/08/2004 | EP1461320A4 Enantioselective transformation of alfa,beta-unsaturated ketones using chiral organic catalysts |
| 12/08/2004 | EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 12/08/2004 | EP1252155B1 Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8- [4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one |
| 12/08/2004 | EP1119548B1 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1h-pyrrole-2,5-dione as glycogen synthase kinase-3 inhibitor (gsk-3) |
| 12/08/2004 | EP1114040B1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY |
| 12/08/2004 | EP0920312B1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
| 12/08/2004 | CN1553909A Benzimidazole and pyridylimidazole derivatives as ligands for GABA receptors |
| 12/08/2004 | CN1553901A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 12/08/2004 | CN1553900A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| 12/08/2004 | CN1553899A Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor and medicinal composition containing the same |
| 12/08/2004 | CN1553814A Remedies for arteriosclerosis |
| 12/08/2004 | CN1178935C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 12/08/2004 | CN1178934C Benzofurane derivatives |
| 12/08/2004 | CN1178933C Photochromic diarylheterocycloethylene compounds sensitive to blue light and its preparing process and usage |
| 12/08/2004 | CN1178932C Amide derivatives |
| 12/08/2004 | CN1178931C Substituted pyrazole compounds |
| 12/08/2004 | CN1178927C Histamine H3 receptor ligands |
| 12/08/2004 | CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 12/08/2004 | CN1178912C Small molecule inhibitors of rotamase enzyme activity |
| 12/08/2004 | CN1178906C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 12/07/2004 | US6828440 Analgesics; side effect reduction |
| 12/07/2004 | US6828344 Direct inhibition of the activity of phospholipase A2 has been suggested as a useful mechanism for a therapeutic agent for inflammation |
| 12/07/2004 | US6828333 Ether derivatives useful as inhibitors of PDE4 isozymes |
| 12/07/2004 | US6828332 Piperidine derivatives as reuptake inhibitors |
| 12/07/2004 | US6828320 Heterocyclic compounds |
| 12/07/2004 | CA2308478C Indole derivatives useful as endothelin receptor antagonist |
| 12/07/2004 | CA2272136C Pyrazole derivatives having crf antagonist activity |
| 12/02/2004 | WO2004103998A1 Quinoline derivatives as phosphodiesterase inhibitors |
| 12/02/2004 | WO2004103992A1 2-aminoquinoline derivative |
| 12/02/2004 | WO2004103977A2 Process for the preparation of pyrimidine derivatives |
| 12/02/2004 | WO2004103968A1 Sulfopyrroles |
| 12/02/2004 | WO2004072031A3 Phenylacetamides and their use as glucokinase modulators |
| 12/02/2004 | WO2004058174A3 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 12/02/2004 | US20040242928 Reverse hydroxamic acid derivatives |
| 12/02/2004 | US20040242873 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 12/02/2004 | US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis |
| 12/02/2004 | US20040242681 6-O-(4-methoxyaniline)acetyl fumagillol for example; superior angiogenesis inhibitory effect with less toxicity, also a cancer metastasis inhibitor, and treats angiogenesis related disorders such as other various inflammatory diseases such as rheumatic disease, psoriasis, and diabetic retinopathy |
| 12/02/2004 | US20040242672 Pyrrolidine derivatives |
| 12/02/2004 | US20040242668 Capable of increasing lipolysis and energy expenditure in cells and therefore is useful for treating Type 2 diabetes and/or obesity |
| 12/02/2004 | US20040242664 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 12/02/2004 | US20040242639 Compounds such as 4-[4-(2-methoxyphenyl)-1-piperazinyl]-3-[[(phenylamino)carbonyl]amino]-benzamide, for therapy of restenosis |
| 12/02/2004 | US20040242633 Compound used to lower cholesterol, reduce weight for dietetics, antidepressants and antidiabetic agents |
| 12/02/2004 | US20040242631 PI-3 kinase inhibitor prodrugs |
| 12/02/2004 | US20040242628 administering N-(1H-Indol-7-yl)-4-nitrobenzenesulfonamide; treating cachexia during cancer therapy |
| 12/02/2004 | US20040242627 2-Iminoimidazole derivatives (1) |
| 12/02/2004 | US20040242615 enhancing the expression of apoAI; prevention or therapy of dislipidemia |
| 12/02/2004 | US20040242613 Pyrimidine derivatives useful as inhibitors of PKC-theta |
| 12/02/2004 | US20040242610 A cis isomer of 1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-5-fluorocytosine has potent activity against hepatitis B virus infection; administration by rectal, nasal, topical, transdermal, vaginal, parenteral, intravenous injection |
| 12/02/2004 | US20040242608 Substituted pyrimidinones |
| 12/02/2004 | US20040242604 Substituted heterocycles for the treatment of abnormal cell growth |
| 12/02/2004 | US20040242603 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor and medicinal composition containing the same |
| 12/02/2004 | US20040242593 Cannabinoid derivatives, methods of making, and use thereof |
| 12/02/2004 | US20040242580 can be applied as sprays by methods commonly employed in crops such as vegetables, fruits, ornamentals, seeds, turf, cereal and vines among other plants |
| 12/02/2004 | US20040242579 Protective coatings; drugs, cosmetics, veterinary medicine; a diaminotriazine compound |
| 12/02/2004 | US20040242574 Anticancer agents; antiarthritic agents |
| 12/02/2004 | US20040242564 1,2,3,4-tetrahydroisoquinolines derivatives |
| 12/02/2004 | US20040242559 Novel indole derivatives, preparation thereof as medicinal products and pharmaceutical compositions, and especially as KDR inhibitors |
| 12/02/2004 | US20040242554 Eating disorders; cognition activators; psychological disorders; anxiolytic agents; sexual disorders; incontinence; antidepressants |
| 12/02/2004 | US20040242506 Formed from paroxetine hydrochloride and ammonium glycyrrhyzinate by precipitation, spray, vacuum or freeze drying, or evaporation to glass; solid or oil; masks the bitter taste of paroxetine and has a distinctive licorice flavor; antidepressants; Parkinson's disease |
| 12/02/2004 | US20040242494 Caspase inhibitors and uses thereof |
| 12/02/2004 | US20040241749 Synthetic molecules for labeling histidine-rich proteins |
| 12/02/2004 | US20040241095 Complex containing cyanine dyes; supplying to target tumor cells |
| 12/02/2004 | CA2526374A1 2-aminoquinoline derivatives |